Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)Antonio Avallone, Alfredo Budillon, Nicola Maurea et al.|BMC Cancer|2014Cited by 41
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.Domenica Rea, Nicola Maurea, Carmela Coppola et al.|PubMed|2017Cited by 31
Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarkerCinzia Lucia Ursini, Delia Cavallo, Emanuela Omodeo Salè et al.|Toxicology Letters|2019Cited by 23
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with <i>RAS</i> -mutated metastatic colorectal cancer: the REVOLUTION study protocolAntonio Avallone, Alfredo Budillon, Maria Carmela Piccirillo et al.|Therapeutic Advances in Medical Oncology|2020Cited by 17
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodologyGiacomo Pascarella, Alessandro Morabito, Arturo Capasso et al.|PLoS ONE|2019Cited by 16